about
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this i...
Read More
43.60
-0.03
(-0.07%)
2.8M
XNAS Volume
XNAS 13 Mar, 2026 5:30 PM (EDT)
Medium Financial Strength
Affordable Valuation
Technically Bearish
Falling Comet
These stocks are medium quality with average financials. However, their weak momentum indicates low investor interest
View Similar
Embed DVM
Sanofi (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..